AQUESTIVE THERAPEUTICS INC. - COMMON STOCK
5.0900
20-September-24 15:59:59
15 minutes delayed
Stocks
-0.1100
-2.12%
Today's range
5.0550 - 5.2900
ISIN
N/A
Source
NASDAQ
-
21 Jul 2021 08:00:01 By Nasdaq GlobeNewswire
-
19 Jul 2021 09:29:40 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film
24 Jun 2021 08:00:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer
21 Jun 2021 09:15:51 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
09 Jun 2021 08:30:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in 2021 RBC Capital Markets Global Healthcare Conference
11 May 2021 09:27:41 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
04 May 2021 19:53:36 By Nasdaq GlobeNewswire
-
21 Apr 2021 09:18:57 By Nasdaq GlobeNewswire
-
25 Mar 2021 08:30:00 By Nasdaq GlobeNewswire
-
09 Mar 2021 17:49:13 By Nasdaq GlobeNewswire
-
05 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
25 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
17 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy
28 Jan 2021 07:30:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics Provides Business Update
07 Jan 2021 07:30:00 By Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
04 Jan 2021 07:30:00 By Nasdaq GlobeNewswire